A somatic mutation in the ATRX gene has been found to be a potential molecular marker for aggressive brain tumors, such as gliomas, neuroblastomas and pancreatic neuroendocrine tumors. Now, for the first time, researchers at at the Perelman School of Medicine at the University of Pennsylvania have found that the same mutated gene may serve as a much-needed biomarker for the pheochromocytomas and paragangliomas (PCC/PGL) that become malignant. These rare neuroendocrine ...
Read More
You have just read an article categorized health
titled Potential Molecular Marker for Aggressive Brain Tumors.
Written by:
editor -
Wednesday, January 21, 2015
There are currently no comments for "Potential Molecular Marker for Aggressive Brain Tumors"
Post a Comment